Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by BS Pharm
Pharmacists as the Center of Prescribing in US Health Care
The US health care system is facing an impending primary care crisis, with 40% of primary care physicians projected to retire or age out within the next 8 years. To address this growing void, clinical leaders are pointing to a highly qualified, yet historically underutilized resource standing behind the pharmacy counter: the pharmacist.
Community Pharmacies Expand Digital, Remote Services During COVID-19
A nationwide cross-sectional survey of Finnish community pharmacy owners found that the early phase of the COVID-19 pandemic accelerated the adoption of digital and remote pharmacy services, with medicine pickup lockers and online pharmacy platforms showing the most pronounced growth.
FDA Approves Tivicay PD to Treat HIV Infection in Newborns
The FDA approved Tivicay PD tablets for oral suspension (dolutegravir) to treat HIV infection in infants from birth up to 4 weeks of age weighing at least 2 kg for use in combination with other antiretroviral agents.1 The approval gives providers a second-generation integrase inhibitor to start eligible newborns with HIV-1 on therapy from birth. | Image Credit: artegorov3@gmail - stock.adobe.com The approval was granted under priority review by the FDA's Center for Drug Evaluation and Research.
Oseltamivir Reduces ICU Admission in Hospitalized Children With Flu
Children hospitalized with laboratory-confirmed influenza who received oseltamivir had a significantly lower hazard of intensive care unit (ICU) admission and a shorter hospital length of stay (LOS) compared with untreated children, according to a cohort study published in JAMA Pediatrics.1 Oseltamivir treatment lowers the hazard of intensive care unit admission and shortens hospital stays in children hospitalized with influenza.
Community Pharmacists Prepare Patients for Summer Travel
The role of the community pharmacist has undergone a transformation, shifting from a traditional dispenser of medications to a specialized provider of travel health and preventive care.1 As international travel becomes increasingly accessible and global disease patterns shift, pharmacists are uniquely positioned as first-line providers for patients preparing to cross borders.
How Nonopioid Pain Protocols Reduce Addiction, Improve Outcomes
The opioid crisis has cost the US billions of dollars and, by some estimates, 1 in 16 patients who receive opioids after surgery goes on to develop an addiction. On top of that, roughly 45,000 people still die from opioid overdose each year. Yet for years, opioids were treated as the default answer for post-operative and acute pain, despite tried-and-true alternatives like NSAIDs, ketorolac, and acetaminophen proving just as effective for most cases, without the risk of addiction.
Sex Differences in COVID-19 Mortality Fades After Vaccine Rollout
A new analysis published in eClinicalMedicine found that the male mortality disadvantage widely reported during COVID-19 was largely a feature of the pandemic's early, prevaccine phase and depended heavily on how researchers measured it.1 Data on excess deaths in high-income countries show the male mortality disadvantage during COVID-19 is concentrated in the pandemic's earliest phase.
Q&A: How Multidisciplinary, Patient-Centered Care Reduces Opioid Dependence
Commentary|Articles|August 5, 2026 Author(s)Brian Nowosielski, Duane Jones, BS Pharm In part 2 of our conversation with Duane Jones, BS Pharm, he moves from nonopioid alternatives to the new and multidisciplinary approaches toward post-operative pain protocols. As pre-operative, operative, and post-operative approaches to care are often handled in silos, many experts believe all 3 transitions of care should be treated together.
Improving Outcomes of Lung Cancer in Never-Smokers
Hospital/Health System • Published July 15, 2026 The number of cases of this biologically distinct disease is growing, and because diagnosis is often made at an advanced stage, treatment options are limited and outcomes typically are poor. Hospital/Health SystemONCOLOGYRESPIRATORYLUNG CANCER US Pharm. 2026;51(7):HS7-HS12. ABSTRACT: Lung cancer is the leading cause of cancer‑related mortality, and most cases are associated with tobacco use.
Psoriasis and Its Associated Psychological Burdens
DERMATOLOGY • Published May 12, 2026 This immune-related dermatologic disease imposes considerable psychological challenges that can markedly impair health-related quality of life. DERMATOLOGYMENTAL HEALTHAUTOIMMUNE US Pharm. 2026;51(5):22-26. ABSTRACT: Psoriasis is a chronic multisystem disease in which dysregulated immune activity leads to rapid epidermal turnover, with plaque psoriasis being the most common type.
Understanding Alzheimer’s Disease and Its Management
US Pharm. 2026;51(1):21-25. ABSTRACT: Alzheimer’s disease (AD), the leading cause of dementia in older adults, is characterized by progressive cognitive decline driven by beta-amyloid and tau pathology. Its prevalence continues to rise, influenced by both modifiable and nonmodifiable risk factors including age, genetics, cardiovascular health, and lifestyle. Diagnosis of AD relies on clinical assessment, imaging, and emerging biomarker testing.
Pneumococcal: Most-Read Stories of 2025
Pneumococcal prevention is entering a sophisticated new chapter where valency, cost, and age-specific epidemiology intersect. This year’s top stories highlight a shifting landscape: while newer vaccines offer broader serotype coverage, their long-term cost-effectiveness is being challenged by the success of childhood herd immunity. Here are the most-read pneumococcal stories of 2025, plus you can read all of our pneumococcal coverage here.
Pharmacists Leverage Accessibility to Provide Reproductive Health Education
Arkansas pharmacists are stepping into a widening gap in reproductive health care—one measured not just in miles to the nearest clinic, but in stark statistics. In a single year, more than 1000 women in Arkansas gave birth without ever seeing a health care provider, according to Duane Jones, BSPharm, regional pharmacy supervisor at Harps Food Stores Inc. At the same time, over 52% of pregnancies in the state are unplanned, and Arkansas ranks fourth in the US for maternal and fetal mortality.
Wegovy Pill Receives FDA Approval as First Oral Weight-Loss Drug
Once-daily oral semaglutide (Wegovy) 25 mg was given FDA approval on Monday for weight management, according to a Novo Nordisk news release.1 This announcement marks Wegovy as the prescription drug market’s very first oral formulation of a glucagon-like peptide-1 (GLP-1) receptor agonist approved to treat excess body weight.
Q&A: Why Pharmacy Is Incentivized to Eliminate HIV Stigma
The collective understanding of HIV has developed significantly throughout the past 25 years and prior, leading to innovative new treatment and prevention options for patients. However, developments in this space have also led to the stigmatization of HIV and the common populations that experience it, which has led community pharmacists to step in and dispel misinformation.
Harps Food Train Pharmacists to Confidently Prescribe Birth Control
Haprs Food Inc in Arkansas is reshaping how women access birth control—and pharmacists are at the center of the change. After the state passed an oral contraceptive prescribing law last year, allowing pharmacists to prescribe hormonal contraception directly to patients, Harps Food saw both an opportunity and a challenge. They discovered how to move beyond a traditional trial-and-error approach and deliver truly evidence-based, patient-centered contraceptive care.
Pharma Pulse: Onshoring Investments and the AI Frontier
Commentary|Podcasts|December 17, 2025 In today’s Pharma Pulse, Novartis and Moderna anchor a domestic manufacturing surge, while AI-driven biomarker discovery and physician well-being reshape the future of clinical care. Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation. I’m your host, and let’s get into today’s headlines.
The Key to Connecting with Patients: Pharma's Market Access Transformation
Years ago, in the era of small-molecule, mass-market pharmaceuticals, the name of the game was market share. Companies were judged on how quickly, and how convincingly, they dominated the market for a therapy class. Field sales reps were incentivized on new prescription (NRx)—the volume of new patients that start on a drug—and there were stories about sales reps so quickly offering price discounts that the drug was actually a loss leader for the manufacturer.
Novartis’ $23 Billion Manufacturing Investment Anchors Industry Shift Toward US Onshoring
Novartis has officially broken ground on a 700,000-square-foot-plus flagship manufacturing hub that is expected to provide end-to-end manufacturing services.1 The project—originally unveiled last month2—will feature the design of a new Morrisville plant, along with a new site in Durham that will include two facilities of its own.
The Next Era of Drug Safety is in Intelligent Action
There is an unwavering dedication to patient safety across the pharmaceutical and biopharmaceutical industry. This focus is embedded in every stage, whether in reliable manufacturing of established treatments or in the development of new therapies. Effective monitoring, detection, and resolution of safety concerns address not only regulatory compliance but also commercial success.
Why Specialty Drugs Dominate Spending, and the Frontline Roles Shaping Patient Access
Megan Wetzel, the VP of product, access, and affordability at CoverMyMeds, is well-versed in the product management, hub solutions, and affordability spaces. Drawing from her decade-plus of experience, she sat down with Pharma Commerce to discuss how specialty drugs continue to account for a disproportionate share of US drug spending, despite representing only a small percentage of prescriptions.
The Great Repricing: How Pharma Must Evolve for Three Diverging Payer Economies
Building on my 2024 “Rise of Cash Pay and Direct-to-Patient (DTP)” and the 2025 “GTN Optimization” series, the 2026 theme—“The Great Repricing”—marks a new era of transformation. The US pharmaceutical market is undergoing a macro realignment in pricing and channel strategy as the traditional commercial insurance–driven model fractures into three competing payer economies. In this first of six articles, we will examine the fragmenting market and its emerging payer realities.
Trade & Channel Strategies 2025: The $405 Billion Patent Cliff Demands Partnership and Adaptive Market Access Strategies
The industry would agree that the life sciences landscape is continuing to change as more generics and biosimilars come into the fold, especially following loss of exclusivity (LOE) of branded drugs.
Pharma Pulse: ACA Subsidy Gridlock Spurs Cost Crisis, as Lilly’s Retatrutide Delivers Positive Results in Phase III Trial
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation. I’m your host, and let’s get into today’s headlines. Starting in Washington, millions of Americans are facing a steep rise in healthcare costs after the Senate failed to advance competing proposals to extend the enhanced Affordable Care Act subsidies.
Americans Call on Policymakers to Prioritize Healthcare Access and Affordability
For far too many Americans, regardless of insurance coverage, increased healthcare-related out-of-pocket (OOP) costs are creating barriers to the care they need and deserve. While it’s important to note that some progress was made in 2025 for people enrolled in Medicare through the Medicare Part D cap,1 premiums and other healthcare costs continue to increase. And individuals with commercial insurance are also facing higher costs, as deductible and OOP spending are becoming unaffordable for many.
The Longer-Term Impact of MFN Pricing
After 17 drug companies received threatening letters to lower US drug prices or face the introduction of most-favored nation (MFN) price controls, Pfizer and AstraZeneca were the first two companies that made an agreement with President Trump. On Nov. 10, the Centers for Medicare & Medicaid Services (CMS) published a “GENEROUS” model1 that is describing the methodology used for MFN pricing arrangements that seems consistent with the Medicaid price concessions in the two deals.
Trade & Channel Strategies 2025: DSCSA Status Following Implementation
The Drug Supply Chain Security Act—or DSCSA for short—was originally signed into law as part of the Drug Quality and Security Act (DQSA) in November 2013 as a way to help bolster security and traceability of products passing through the pharma supply chain.1 It’s enforced by the FDA.
Trade & Channel Strategies 2025: Trade and Channel Strategies in the Era of Medically Integrated Dispensing
News|Videos|December 11, 2025 Author(s)Nicholas Saraceno, Editor, Cheryl Allen, BS Pharm, MBA, Curatio Scientia Advisors, Nicholas Jacobus Cheryl Allen, BS Pharm, MBA, founding partner, Curatio Scientia Advisors, discusses how the convergence of patient access services with traditional distribution models is setting the stage for medically integrated dispensing to expand beyond oncology.
Pharma Pulse: FDA Fast-Tracks Antibiotic Approval, as Protected EHR Time Combats Physician Burnout
Commentary|Podcasts|December 11, 2025 In today’s Pharma Pulse, Augmentin XR is the first drug approved under the FDA's new CNPV pilot program and much more. Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation. I’m your host, and let’s get into today’s headlines. First, the FDA has opened the throttle on a new fast-track system.
Trade & Channel Strategies 2025: Channel Evolution Over the Last 20 Years
News|Videos|December 10, 2025 Author(s)Nicholas Saraceno, Editor, Cheryl Allen, BS Pharm, MBA, Curatio Scientia Advisors, Nicholas Jacobus Cheryl Allen, BS Pharm, MBA, founding partner, Curatio Scientia Advisors, highlights how two decades of commercial trade and distribution have transformed the channel from a primarily supply-chain-focused function into a more integrated discipline.
Weekend Doctor: Healthcare concerns of dietary supplements
By Tenna Rhonemus, BS Pharm, RPh, BCGP Pharmacy Supervisor of Outpatient Services, Blanchard Valley Health System Dietary supplements have surged in popularity in recent years as more individuals turn to self-directed wellness routines. Common dietary supplements include vitamins, minerals, herbs, amino acids, and probiotics. Available in pharmacies, grocery stores, and online retailers, these products are marketed with promises of enhanced immunity, increased energy, and improved overall health.
The Expanding Role of Biosimilars in Autoimmune Diseases
US Pharm. 2025;50(6):25-28. ABSTRACT: On March 6, 2015, the FDA approved filgrastim-sndz as the first biosimilar in the United States. Since then, the biosimilar market has expanded significantly, offering several benefits, such as providing comparable, cost-effective, equally effective therapeutic alternatives to their biological reference product while maintaining high quality, safety, and efficacy standards.
Q&A: Revenue Impact and Clinical Service Expansion Opportunities
Q&A – Business Impact and Future Opportunities Main Discussion Topics: Revenue impact of point-of-care testing Opportunities for complementary product recommendations Future evolution of pharmacy clinical services Key Points for Physicians: Point-of-care testing creates opportunities for appropriate OTC product recommendations Testing services often attract patients not previously using the pharmacy Testing programs can expand into additional clinical services such as contraceptive...
Q&A: Resources and Legislative Advocacy for Point-of-Care Testing
Q&A – Staff Training and Legislative Advocacy Main Discussion Topics: Resources for point-of-care testing staff training Legislative advocacy strategies for pharmacy practice expansion Expansion to additional clinical services (contraceptive prescribing) Key Points for Physicians: CPESN provides valuable resources for protocol development Developing relationships with state legislators supports practice expansion initiatives Pharmacy-based testing can lead to expanded clinical service...
Q&A: Getting Started with Point-of-Care Testing in Community Pharmacy
Q&A – Getting Started with Implementation Main Discussion Topics: Initial steps for implementing point-of-care testing in community pharmacy Time management and workflow integration Pharmacist acceptance and adoption process Key Points for Physicians: State regulations for pharmacy-based testing vary significantly; consultation with board of pharmacy is essential Pharmacies handling up to 900 prescriptions daily successfully integrate testing without additional staffing Medication...
Case Studies and Value Demonstration in Pharmacy-Based Point-of-Care Testing
Case Studies and Implementation Strategies Main Discussion Topics: Practical implementation experiences in community pharmacy Cost-saving potential for health systems Medication synchronization as an operational foundation Key Points for Physicians: Pharmacies following clinical protocols can reduce unnecessary prescribing and testing Pharmacy-based services can significantly reduce emergency department (ED) visits and hospitalizations Formal service structure positions pharmacists as...
Regulatory Requirements and Credentialing for Pharmacy-Based Point-of-Care Testing
Regulatory Framework and Credentialing Main Discussion Topics: CLIA waiver requirements and regulatory compliance Pharmacist credentialing process with payers Documentation and protocol development importance Key Points for Physicians: 48 states allow pharmacists to perform point-of-care testing Pharmacy testing requires CLIA waivers Pharmacies must establish protocols similar to those in medical practice settings Notable Insights: Credentialing is a one-time process that creates ongoing...
Benefits of Point-of-Care Testing in Community Pharmacy Practice
Introduction and Value Proposition Main Discussion Topics: Point-of-care testing as a revenue driver for community pharmacies Addressing health care deserts through accessible pharmacy services Strengthening provider relationships through complementary care Key Points for Physicians: Point-of-care testing in pharmacies can complement physician care Services include COVID-19, influenza, streptococcal infection, hemoglobin A1c, and cholesterol testing Pharmacies see patients approximately 33...
AI for Detecting and Preventing Adverse Drug Events
US Pharm. 2025;50(2):32-37. ABSTRACT: Artificial intelligence (AI) is revolutionizing healthcare. Pharmacists should be aware how AI can affect the medication-use process, including the detection and prevention of adverse drug events (ADEs).
Transforming Specialty Pharmacy Engagement
February 4, 2025 By A report offers a comprehensive benchmarking and assessment of pharmaceutical manufacturer engagement with specialty pharmacies. The specialty pharmacy channel plays a pivotal role in supporting patients who require complex and life-changing therapies. These pharmacies not only distribute specialty medications but also deliver critical patient support services, such as adherence programs, financial assistance navigation, and clinical expertise.
NCPA's New Consortium Exemplifies Preparedness in Community Pharmacy
The National Community Pharmacists Association (NCPA) recently announced the formation of the Independent Community Pharmacy Consortium for Government Engagement. Designed to create a framework for pharmacies, organizations, and other entities within the pharmaceutical supply chain, NCPA is spearheading this consortium with hopes of alleviating future public health crises.
La budesonida a largo plazo muestra una eficacia sostenida en la esofagitis eosinofílica
Editado por Vinod Rane CONCLUSIÓN PRÁCTICA Los comprimidos bucodispersables de budesonida mantienen la remisión y mejoran la calidad de vida en la mayoría de adultos con esofagitis eosinofílica durante un máximo de 144 semanas. DISEÑO DEL ESTUDIO Existe una necesidad urgente de datos a largo plazo sobre la farmacoterapia en la esofagitis eosinofílica, dado que los pacientes con esta enfermedad crónica a menudo experimentan recaídas tras la interrupción del tratamiento.
Enhancing Patient Safety Through Critical Drug Label Improvements
By Amir Emamifar, BS Pharm, PharmD, MBA In the fast-paced environment of hospitals and healthcare facilities, where healthcare staff are often overburdened and facing critical shortages, the need for patient safety measures is paramount. With healthcare providers managing multiple patients simultaneously, the risk of medication errors has significantly increased.
Controlar seis factores de riesgo puede combatir la enfermedad renal crónica en la obesidad
CONCLUSIÓN PRÁCTICA El control óptimo de la presión arterial, los niveles de hemoglobina glucosilada (HbA1c), el colesterol de lipoproteínas de baja densidad (c-LDL), la albuminuria, el tabaquismo, así como la actividad física pueden reducir el exceso de riesgo de enfermedad renal crónica típicamente asociado a la obesidad. El efecto protector es más pronunciado en los hombres, en las personas con menor puntuación en alimentación saludable y en los usuarios de medicación para la diabetes.
09.14.24 -- Clinical Leader Best Of August
AUGUST'S BEST FEATURED EDITORIAL Easy Mistakes To Make During An FDA Inspection As a former FDA investigator, Vincent Cafiso has heard — and seen — it all when it comes to what NOT to do during an FDA inspection. Here he gives some good advice on who you should have present in the room during an inspection and how you should interact with the investigator. What Clinical Trial Information Do VCs And Investors Actually Want?
Standardizing Diversion Investigations
Click on a product name to expand the listing. Click this icon to request more information on a product. WHERE TO FIND Diversion Software For a full list of vendors offering Diversion Software, go to: www.pppmag.com/findit Key Diversion Software Suppliers
Treating Pediatric and Adolescent Impetigo
US Pharm. 2024;49(8):8-12. ABSTRACT: Impetigo is a common bacterial skin infection that is primarily caused by two pathogens: Staphylococcus aureus and Streptococcus pyogenes. Its highly contagious nature poses a health concern, especially among young children. Impetigo is divided into two main variants: nonbullous and bullous. Diagnosis is often made based on the clinical presentation and supplemented by cultures.
Sleep for Mental Health at Work? It May Be More Important Than You Think
Sleep is a foundational requirement for mental health, even in the workplace. Proper sleep equips you with the tools to respond appropriately to situations by enhancing the connection between your emotions and the context of events occurring in different parts of the brain. How do you ensure you get the proper amount of sleep? Focus on these four factors: Quantity Quantity refers to the total sleep duration a person gets within 24 hours.
A Review of First-Time Generic Drug Approvals
US Pharm. 2024;49(6):35-40. ABSTRACT: As healthcare costs and the number of individuals diagnosed with and treated for medical conditions continue to rise, the availability of generic drugs gives patients increased access to affordable, safe, and effective therapies and can enhance medication adherence.
The Best Project Management Methodology Isn't Traditional Or Agile - It's Both
Guest Column | June 11, 2024 By Aurea M. Flores, Ph.D., BS Pharm, CCRP, CHRC, CHC, CHPC, CCEP, PMP, PMI-ACP, RQAP-GCP Traditional project management methodology follows a linear progression from beginning to end, which should theoretically work for clinical trial development. However, in my experience as a former director of clinical research operations, this method yielded a success rate for timely trial opening of less than 5%.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with BS
Contact BS, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack